Cancer pill costs soar as drug companies retain pricing power https://t.co/Us5ilh9vAa via @FT
— The Propell Group (@ThePropellGroup) May 1, 2017
#healthtech
Cancer pill costs soar as drug companies retain pricing power https://t.co/Us5ilh9vAa via @FT
— The Propell Group (@ThePropellGroup) May 1, 2017
#healthtech